Showing results (141-150 of 311) with videos related to
Sort By:
Pageof 32
Cureus|February 13, 2025
Assessment of Local and Regional Control in High-Risk Atypical (WHO Grade 2) Meningiomas Receiving Stereotactic Fractionated RadiosurgeryRoman Travis, Madyson Taylor, Christopher Willey, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 26, 2013
Self-reported non-severe hypoglycaemic events in EuropeC G Östenson, P Geelhoed-Duijvestijn, J Lahtela, et al.Journal of Radiosurgery and SBRT|April 17, 2018
Evaluation of multiple factors affecting normal brain dose in single-isocenter multiple target radiosurgeryYu Yuan, Evan M Thomas, Grant A Clark, et al.Clinical Neuropathology|April 10, 2007
Necrotizing neurosarcoid: three cases with varying presentationsJ M Markert, K Powell, R S Tubbs, et al.Cancer Gene Therapy|January 29, 2005
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12Jacqueline N Parker, Sreelatha Meleth, Kenneth B Hughes, et al.Pflugers Archiv : European Journal of Physiology|November 3, 2001
Cardiovascular effects of fentanyl in conscious ratsF Baechtold, C Cavadas, D Gasser, et al.International Journal of Breast Cancer|January 25, 2013
Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastasesJames J Cody, Pietro Scaturro, Alan B Cantor, et al.Surgical Neurology International|December 18, 2015
Intracranial blastomycotic abscess mimicking malignant brain neoplasm: Successful treatment with voriconazole and surgeryKanika Arora, Ross L Dawkins, David F Bauer, et al.Biology Open|November 5, 2020
Overexpression of an ALS-associated FUS mutation in <i>C. elegans</i> disrupts NMJ morphology and leads to defective neuromuscular transmissionSebastian M Markert, Michael Skoruppa, Bin Yu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 19, 2000
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumorsJ N Parker, G Y Gillespie, C E Love, et al.Pageof 32